HeartBeam, Inc.
BEATNASDAQHealthcare● Active
$0.81
$-0.03(-3.44%)
Market Cap$27899284
P/E Ratio—
52W High$4
52W Low$0.54
HeartBeam, Inc. (BEAT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BEAT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.12
Est. -$0.14 · +14.3%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
BEAT reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.10 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 13, 2026 | -$0.14 | -$0.12 | +14.3% | — | $0.00B | — |
| ▼ Q1 FY2026 | Mar 12, 2026 | -$0.13 | -$0.14 | -7.7% | — | $0.00B | — |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$0.16 | -$0.15 | +6.3% | — | $0.00B | — |
| ▲ Q3 FY2025 | Aug 13, 2025 | -$0.16 | -$0.15 | +6.3% | — | — | — |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.15 | -$0.18 | -20.0% | — | — | — |
| ▲ Q1 FY2025 | Mar 13, 2025 | -$0.19 | -$0.18 | +5.3% | — | — | — |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.17 | -$0.19 | -11.8% | — | — | — |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.10
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Beat
EPS Actual
-$0.12
EPS Est.
-$0.14
EPS Surpr.
+14.3%
Revenue
—
Q1 FY2026
Mar 12, 2026Miss
EPS Actual
-$0.14
EPS Est.
-$0.13
EPS Surpr.
-7.7%
Revenue
—
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$0.15
EPS Est.
-$0.16
EPS Surpr.
+6.3%
Revenue
—
Q3 FY2025
Aug 13, 2025Beat
EPS Actual
-$0.15
EPS Est.
-$0.16
EPS Surpr.
+6.3%
Revenue
—
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$0.18
EPS Est.
-$0.15
EPS Surpr.
-20.0%
Revenue
—
Q1 FY2025
Mar 13, 2025Beat
EPS Actual
-$0.18
EPS Est.
-$0.19
EPS Surpr.
+5.3%
Revenue
—
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.19
EPS Est.
-$0.17
EPS Surpr.
-11.8%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.03 | $-0.02 | $-0.00 | 1 |
| Q3 FY2028 | $-0.03 | $-0.02 | $-0.01 | 1 |
| Q2 FY2028 | $-0.02 | $-0.01 | $-0.00 | 1 |
| Q1 FY2028 | $-0.03 | $-0.02 | $-0.01 | 1 |
| Q4 FY2027 | $-0.11 | $-0.06 | $-0.02 | 1 |
| Q3 FY2027 | $-0.12 | $-0.07 | $-0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +14.3% | $0.91 | $1.01 | +10.79% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -7.7% | $1.36 | $1.47 | +8.09% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +6.3% | $1.67 | $1.57 | -5.99% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +6.3% | $1.20 | $1.20 | +0.00% |
| ▼ Q2 FY2025 | May 13, 2025 | -20.0% | $1.72 | $1.71 | -0.58% |
| ▲ Q1 FY2025 | Mar 13, 2025 | +5.3% | $2.08 | $2.02 | -2.88% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -11.8% | $2.51 | $2.33 | -7.17% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -18.8% | $2.25 | $2.27 | +0.89% |
Q2 FY2026+10.79%
Report Date
May 13, 2026
EPS Beat/Miss
+14.3%
Price Before
$0.91
Price After
$1.01
Q1 FY2026+8.09%
Report Date
Mar 12, 2026
EPS Beat/Miss
-7.7%
Price Before
$1.36
Price After
$1.47
Q4 FY2025-5.99%
Report Date
Nov 13, 2025
EPS Beat/Miss
+6.3%
Price Before
$1.67
Price After
$1.57
Q3 FY2025+0.00%
Report Date
Aug 13, 2025
EPS Beat/Miss
+6.3%
Price Before
$1.20
Price After
$1.20
Q2 FY2025-0.58%
Report Date
May 13, 2025
EPS Beat/Miss
-20.0%
Price Before
$1.72
Price After
$1.71
Q1 FY2025-2.88%
Report Date
Mar 13, 2025
EPS Beat/Miss
+5.3%
Price Before
$2.08
Price After
$2.02
Q4 FY2024-7.17%
Report Date
Nov 7, 2024
EPS Beat/Miss
-11.8%
Price Before
$2.51
Price After
$2.33
Q3 FY2024+0.89%
Report Date
Aug 14, 2024
EPS Beat/Miss
-18.8%
Price Before
$2.25
Price After
$2.27
Avg Beat Reaction+0.48%
Avg Miss Reaction+0.31%
Beat Rate4 / 8 quarters
Largest Move+10.79% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BEAT ends December
HeartBeam, Inc. (BEAT) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.12 — beating the analyst consensus of $-0.14 by +14.3%. The next BEAT earnings date is expected around September 1, 2026.
Each quarter, investors track BEAT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BEAT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BEAT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BEAT earnings · 5 questionsHeartBeam, Inc.'s next earnings report is expected around September 1, 2026. BEAT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BEAT historically reports after market close (AMC).
BEAT earnings datewhen is BEAT earningsBEAT next earnings datewhen does BEAT report earningsBEAT earnings calendar
▸ Source: FMP · HeartBeam, Inc. SEC filings · US GAAP · HeartBeam, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026